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Abstract: Anthocyanins are dietary bioactive compounds showing a range of beneficial effects against
cardiovascular, neurological, and eye conditions. However, there is, as for other bioactive compounds
in food, a high inter and intra-individual variation in the response to anthocyanin intake that in
many cases leads to contradictory results in human trials. This variability could be caused at two
levels, one at the bioavailability level and the other at the effect and mechanisms of action. In this
context, we have thoroughly reviewed the scientific literature on anthocyanins variability caused by
variation in bioavailability. Based on the literature reviewed, we have concluded that the variability
in anthocyanins bioavailability might be produced by the lack of homogeneity introduced at three
different levels: food matrix and food processing, enzymes involved in anthocyanin metabolism
and transport, and anthocyanin metabolizing gut microbiota. However, it should be noted that the
literature on anthocyanins bioavailability considering inter or intra-individual variability is still very
scarce, which makes it difficult to reach any firm conclusion on the main metabolizing enzymes or
bacteria that would be responsible for the variability in anthocyanin bioavailability.
Keywords: anthocyanin; variability; bioavailability; food processing; metabolism; microbiota
1. Introduction
Anthocyanins receive attention and are studied both because of their impact on food sensory
properties, being responsible for the red-blue color of berries, fruits, and certain vegetables-based
products, and because of their health-promoting properties [1–5].
Anthocyanins and anthocyanin-rich foods have been shown to display several biological activities
which may have positive implications on human health, including anti-inflammatory, anti-diabetic,
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and antioxidant activities [2,3]. Especially important is their role in preventing cardiovascular health
disease through modulation of risk factors such as blood pressure, platelet aggregation, and vascular
function [1,5,6]. Furthermore, the intake of anthocyanins seems to have promising effect on cognitive
function in humans, with both acute and long-term intakes [4]. Besides, no negative effect of
anthocyanin derivatives has been reported, even after ingestion of very high doses [7].
However, the effectiveness of anthocyanins in protecting consumers against chronic diseases
depends on numerous factors, which, among others, are influenced by their bioavailability, that is,
absorption, metabolism, distribution, and excretion (ADME). Ingested anthocyanins may be efficacious
for one individual, but may not trigger the same effect for another. This variability in response to
anthocyanins may be due to an inter-individual variation in the absorption and metabolism of these
substances or might also be due to a variability on their intrinsic effect to target genes or proteins.
An important role in this variability may be ascribed to intrinsic aspects such as genetics, age, sex, and
physiological or pathological states. Genetic variation for enzymes involved in the absorption and
metabolism of anthocyanins may result in large differences in the expression of a functional enzyme.
The mentioned aspects are part of a phenomenon known as inter-individual variability in response to
bioactive compounds.
Differences in a person’s gut microbiota and metabolizing enzymes will influence ADME of
anthocyanins and consequently, their bioactivity and exerted health effects. It is also important
to note that the chemical form of anthocyanins and the food matrix in which these pigments are
dispersed in combination with individual physiological variability may be critical factors determining
anthocyanin bioavailability.
Consequently, the same dietary intake of anthocyanins can result in different concentration
absorbed and different metabolites and consequently, different health effects. In fact, this could
be the reason for conflicting or contradictory results of clinical studies on effects of anthocyanins.
The aim of this paper is to thoroughly review previous work on anthocyanins bioavailability, in
order to assess inter-individual variation in anthocyanins bioaccessibility in humans and to evaluate
how it is influenced by food processing, the variability in the enzymes involved, and human gut
microbiota composition.
2. Methodology
A systematic literature review was undertaken to better understand anthocyanin metabolism
and inter-individual variability after anthocyanin intake. Databases (Web of Science and PubMed)
were searched for articles written in English and published between January 2000 and August 2018.
Keywords used for the bibliographical search were [anthocyanin OR cyanidin OR pelargonidin
OR delphinidin OR peonidin OR petunidin OR malvidin] AND [bioavailability OR absorption OR
metabolism OR urinary excretion OR plasma OR urine OR pharmacokinetic OR conjugated OR
glucuronide OR sulfat* OR sulphat* OR methylat* OR gut OR colon] AND [volunteer OR in vivo OR
intervention OR human]. As a result of these searches, we found 1319 papers in the Web of Science
and 1426 papers in PubMed databases. Papers found irrelevant for our objective, duplicated papers, or
conflicting ones were excluded from the study. After the elimination, we obtained 86 papers that were
in accordance with the aim of this work, that is, influence of the type of food processing, the variability
in the enzymes involved in anthocyanin metabolism, and human gut microbiota composition on
anthocyanin bioavailability. However, only four of these papers dealt with inter-individual variability
of anthocyanins bioavailability.
3. Anthocyanin Structure and Distribution
Anthocyanins are water-soluble pigments belonging to the flavonoid group of polyphenols [8,9].
They have glycosidic structure, that is, one or more sugar molecules (glucose, galactose, rhamnose,
xylose, or arabinose) bound to the aglycon, the anthocyanidin. The sugar can be acylated with aliphatic
acids (malonic, succinic, malic, and acetic acid) or cinnamic acids (p-coumaric, ferulic, and sinapic
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acid) [8,9]. Anthocyanins differ in (i) the position and number of hydroxyl groups, (ii) the degree of
methylation of hydroxyl groups, (iii) the nature and number of sugar molecules attached to the aglycone,
and (iv) and aliphatic or aromatic acids attached to the sugar molecule [8]. In nature, more than 600
individual anthocyanins and more than 30 anthocyanidins have been identified [2,9], but only six
aglycones are common and widely distributed in foods: pelargonidin, cyanidin, peonidin, delphinidin,
petunidin, and malvidin (Figure 1). Most of the anthocyanins in foods are cyanidin derivatives,
followed by delphinidin and pelargonidin and the three methylated anthocyanins, peonidin, malvidin,
and petunidin [9]. Cyanidin-3-glucoside is the most widely distributed anthocyanin in edible plants
and consequently, is the most studied compound [10–12].
Figure 1. Anthocyanidin structure.
The main dietary sources of anthocyanins are pigmented fruits and vegetables such as berries,
grapes, pomegranates, eggplant, and red cabbage and products derived of these commodities, for
example, juices and red wines [7,10]. The daily intake of anthocyanins is estimated to be 12.5 mg
per person in the United States [10], however, anthocyanin intake shows a huge variability between
individuals due to their content being restricted to a few food items. In this sense, a recent cohort study
showed values for anthocyanin intake to be below 9.2 mg/d in the first quintile to more than 23.2 mg/d
in the higher quintile [13].
4. Effects of Food Processing and Food Matrix
Food processing influences both content and bioaccessibility of anthocyanins. The bioaccessibility
of anthocyanins is dependent on the food matrix, on other food components like alcohol and fat,
as well as on the structure of the anthocyanin [14]. Acylation increases anthocyanin stability and
substantially declines bioavailability [15,16]. Anthocyanidin structure is a determinant of bioavailability,
with pelargonidin-based anthocyanins (3′-hydroxyanthocyanins) being more readily absorbed than
anthocyanins with more substituents on the B-ring [17]. Structure of the anthocyanidin backbone,
the presence or lack of glycosylation and hydroxylation of the basic flavylium structure, and the
number, type, and acylation of bounded sugar molecules are linked to plant species and imply
characteristic anthocyanins’ patterns. Therefore, the plant species and food matrix are very significant
factors that determine the content and bioaccessibility, and thus the bioavailability of anthocyanins.
Anthocyanin bioavailability might also be modified by food pH and temperature [14]. Moreover, the
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presence of other constituents, which were formed and/or added within technological processes, liable
to bind, solubilize, or stabilize anthocyanins could modify the bioavailability of the anthocyanins.
Food processing, including home food preparation practices, is one of the main factors determining
anthocyanins stability and interaction with the food matrix. Several previous studies discuss the effect
of plant species, food processing, and food matrix on anthocyanins content. However, knowledge
about the impact of the above factors on anthocyanins bioavailability is limited. A summary of studies
exploring the effect of thermal and nonthermal processing conditions on anthocyanins content and
bioaccessibility and bioavailability are presented in Table 1. In general, thermal processing results in a
decrease of anthocyanin contents and an increase of anthocyanins bioaccessibility and bioavailability.
Thermal treatments damage cell walls, liberating the cytoplasmic content and making the anthocyanins
more accessible for absorption [18,19].
Table 1. Effect of technology and processing conditions on bioaccessibility and bioavailability
of anthocyanins.
Technology and






(900 W, 12–20 min)
Purple carrots (Daucus
carota) ↓ (23% total ACs)
↓ 11-14-fold ↓ACs


















Grape/blue berry ↑ (213.8%) ↓ [23,24]
Fermentation (at 18–24 ◦C,
pH 3.80, 14 days)
Red cabbage (Brassica
oleracea) ↓ (15%) ↓ [25]
Domestic cooking






Very high recovery ≈ [26]
* ACs: anthocyanins. ↑: increase in bioaccesibility/bioavalability of anthocyanins; ↓: decrease in
bioaccesibility/bioavalability of anthocyanins; ≈: bioaccesibility/bioavalability of anthocyanins was un-changed.
Several in vitro and in vivo studies have reported both positive and negative effects of other
co-ingested food components on anthocyanins bioaccessibility [20–26] (Table 1). These contradictory
results may be due to differences in the type of anthocyanin, the degree and type of food processing,
including exposure to different pH, temperature, light conditions, and the presence of metal ions or
oxygen [27]. A study with hyperlipidemic rabbits reported a higher anthocyanin absorption rate from
blackcurrant juice versus an aqueous citric acid solution of purified anthocyanins, suggesting a possible
increase in bioavailability resulting from the inclusion of the anthocyanin in a food matrix [28]. On the
other hand, in humans, the anthocyanin peak plasma concentration was delayed with co-ingestion of
blackcurrant juice with rice cake, whereas no effect was observed for total absorption or excretion of
anthocyanins. The results of the study indicated that the rice cake prolonged the stay in the stomach
with a slower uptake of anthocyanins from the intestine [28]. A study in humans with consumption of
strawberries with or without cream showed no significant difference in plasma and urinary excretion
between groups, however, the time required to reach the maximum serum level was delayed in
subjects consuming strawberries with cream, suggesting the slowing effect of fat on anthocyanins
gastric transit [29]. Additionally, it has been reported that the in vivo antioxidant activity of dark
chocolate is reduced by either the effect of milk during intake or the manufacturing process, due to
the possible interaction between flavonoids and milk proteins [30]. Additionally, in a human trial,
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Wiczkowski et al. [25] showed that bioavailability of anthocyanins from fresh red cabbage was higher
when compared with fermented red cabbage. The results obtained by Kurilich et al. [20] indicated
that the bioavailability of carrot anthocyanins was unaffected by cooking, although cooking increased
relative urinary recoveries of nonacylated anthocyanins, but not of acylated anthocyanins.
Also, a few bioavailability studies have investigated the effects of meal composition and other
constituents on anthocyanin absorption. Bub et al. [31] suggested that higher glucose content in
food products could delay anthocyanins absorption, which could result from competitive action of
glucose and anthocyanin on the sodium-dependent glucose cotransporter SGLT1. In another study,
Mulleder et al. [32] compared the urinary excretion of anthocyanins when elderberry concentrates
were consumed with and without sucrose and showed that urinary recovery of anthocyanins was
lower after sucrose consumption. Moreover, the consumption of elderberry juice with sucrose resulted
in delaying anthocyanin excretion. A similar phenomenon was found by Walton et al. [33], who in
an experiment with pigs showed that that co-consumption of other foods delayed the absorption of
anthocyanins from blackcurrant but did not influence the maximum plasma concentration (Cmax) and
area under the curve (AUC) values.
Regarding alcohol, results are also controversial. While Bub et al. [31] showed that bioavailability
of malvidin-3-glucoside was not significantly different after the consumption of either red wine or
dealcoholized red wine in absolute terms, they found that alcohol was able to speed up the absorption
(tmax = 50 min for wine and 90 min for dealcoholized red wine). However, Frank et al. [34] did not
find that the bioavailability of anthocyanins was significantly affected by alcohol consumption.
McDougall et al. [35] studied the bioavailability of raspberry anthocyanins using an in vitro
digestion system, showing that anthocyanins were stable to gastric conditions, whereas they were
poorly recovered following pancreatic digestion and that the bioavailability was not affected by joint
consumption with different complex food products. Similarly, Sengul et al. [36], using an in vitro
gastrointestinal digestion model to study the bioaccessibility of pomegranate anthocyanins, reported
that 89% of anthocyanins were stable in gastric conditions, whereas this ratio was just 38% after
pancreatic digestion, and only 12% was available in the serum. Among the studied foodstuffs, only
meat, soymilk, and cream co-digestion resulted in a loss in serum anthocyanin levels. They concluded
that proteins decreased and carbohydrates and fatty acids increased the total anthocyanins content
in serum.
Conversely, Ribnicky et al. [37], when investigating the effects of different digestive conditions
on the bioaccessibility of blueberry anthocyanins using the Netherlands Organisation for applied
scientific research (TNO) gastrointestinal model (TIM-1), concluded that the lipid-rich matrices did not
affect anthocyanin bioavailability, whereas protein-rich matrices protected anthocyanins during transit
through the upper digestive tract.
Again, in an in vitro gastrointestinal digestion model, Pineda-Vadillo et al. [26] concluded that
anthocyanins remain stable and soluble during the oral and gastric steps of digestion, whereas
many of them are extensively modified or insolubilized during the intestinal step of digestion.
Both thermal degradation and fat and protein interactions decreased anthocyanin bioavailability in
this study. Regarding other food components, docosahexaenoic acid (DHA) significantly decreased the
bioaccessibility of anthocyanins [38].
5. Effect of Enzymatic Variability
After consumption, a very low proportion (<2%) of the original anthocyanins are retrieved in the
circulation (plasma/urine) [39]. However, we now know that after ingestion, anthocyanins are subjected
to pH-dependent transformations and are hydrolyzed by several enzymes in the small intestine [40].
The released aglycon can enter the epithelial cells by passive diffusion, or a sodium-dependent glucose
transporter (SGLT-1) can be involved in the transport of the glycosides (anthocyanins). A portion of
the ingested anthocyanin reaches the large intestine, where they are metabolized by the gut microbiota
to a range of low-molecular-weight catabolites (phenolic acids and other phenols), which are excreted
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in the feces or absorbed again. Once absorbed, the anthocyanins and their catabolites undergo
phase 2 enzymatic metabolism, first in the wall of the intestine, then are further converted in the
liver, that is, the compounds formed are glucuronidated, sulphated, and methylated, catalyzed by
UDP-glucuronosyltransferases (UGTs), sulphotransferases (SULTs), and catechol-O-methyltransferases
(COMT), respectively. Anthocyanins present the particularity, when compared with other flavonoids,
of being absorbed in their native form, as glycosides [41].
Conjugation reactions, particularly sulfation, glucuronidation, and methylation, are known
to be involved in the metabolism of phenolic compounds in the human body, generally resulting
in stabilization and increased water solubility, and therefore, modifying their distribution and
excretion. Sulfation of phenolic compounds is mediated by cytosolic sulfotransferases (SULTs).
SULTs catalyze the transfer of a sulfonate group from 3-phosphoadenosine-5-phosphosulfate to a
substrate containing a hydroxyl group. The isoforms SULT1A1, SULT1A3/4, SULT1B1, SULT1E1, and
SULT2A1 are considered the most relevant in polyphenol metabolism in human adults. Methylation
catalyzed by COMT is another metabolic pathway of phenolic compounds [42]. Protocatechuic
acid-O-sulfate, vanillic acid-4-O-sulfate, and ferulic acid-4-O-sulfate were plasma metabolites of
13C-labelled cyanidin-3-glucoside [43].
Glucuronidation of phenolic compounds is mediated by the uridine diphosphate
(UDP)-glucuronosyltransferases. Glucuronidation is a major metabolic pathway that promotes
the elimination of drugs and other potentially toxic exogenous and endogenous compounds, and the
existence of inter-individual variability in drug glucuronidation leading to ineffective drug levels or
drug toxicity has been reported (Table 2). The individual UGT isoforms expressed in the human liver
and ranked from most to least abundant are UGTs 1A1, 1A3, 1A6, 1A9, 2B4, 2B7, 2B10, 2B15, and
2B17. Also, variability in UGT activities has been reported. Possible factors influencing UGT activity
variability have been reported as age, sex, genetic polymorphism, and enzyme inducers. Several
reviews reported the ontogeny of hepatic drug glucuronidation [44,45]. According to these reviews,
prior to, and immediately following, birth, the liver appears to have limited ability to glucuronidate
drugs. In initial studies, it was shown that fetal human livers had very low ability to glucuronidate
phenolic substrates, which are glucuronidated by UGT1A [46]. Strassburg et al. [47], studied UGT
expression in fetal, pediatric (6–24 month), and adult human livers, showing that none of the UGTs
were detected in fetal human liver. In contrast, all UGTs expressed in adult liver were determined in
pediatrics by 9 months of age. Bolling et al. [48] concluded in a study done in rat liver microsomes
from male F344 that the capacity for flavonoid glucuronidation by rat liver microsomes was dependent
on age, UGT isoenzymes, and flavonoid structure. Old age appears to have a minimal effect on
UGT function.
Several UGTs including UGT2B15 and UGT1A6 have been shown to display higher activities in
males than in females. Buckley and Klaassen [49] investigated the tissue- and gender-specific mRNA
expression patterns of mouse UGT. They observed that UGT1A1, 1A2, 1A5, and 1A10 and UGT2B1,
UGT2B5/37/38 are significantly different between male and female mice in liver and kidney. However,
UGT1A7, 1A8, and 1A10, which play a key role in the conjugation and detoxification of numerous
phenolic compounds, did not show gender-specific differences. Based on these results we can say that
UGT activities depend on tissue, gender, and type of UGT.
Enzyme inducers, including coadministered drugs, smoking, and alcohol, may increase hepatic
UGT levels [46]. Hollands et al. [21] investigated urinary excretion of strawberry anthocyanins, which
are mainly pelargonidin-3-glucoside. The main metabolite identified in the urine samples was a
pelargonidin-monoglucuronide. Although the dose excretion curve was linear for all individuals, there
was individual variation in urinary anthocyanin yields, probably due to differences in UGT levels or
activity. An effect of diet on UGT1A enzyme activity, as measured by serum bilirubin, has been shown.
An increase in UGT1A enzyme activity has been reported for vegetable-containing diets, proving that
dietary habits may modulate enzyme activity so that phenolic compounds ADME can be affected [50].
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Table 2. Enzymes or enzyme families participating in anthocyanin metabolism that have shown
variability at different levels.




sulfates Small intestine [51]
GBA1, GBA2, GBA3-1,












Glucuronates Age, smoking [48]
UGT1A1, UGT1A2,









Mallery et al. [52] studied patient-specific differences in local retention and metabolism of
freeze-dried black raspberries’ components in oral cavities of 10 healthy individuals and investigated
metabolic profiling of the enzymes in tissues obtained from 15 donors. They proposed that as the
mouth is contiguous with the more distal components of the gastrointestinal tract, oral cavity enteric
recycling is logical and plausible. They reported that oral microflora, salivary enzymes, and surface
of oral epithelium contributed to intraoral bioactivation of anthocyanins via β-glucosidase activity.
High levels of inter-donor differences in β-glucosidase activities were observed. Phase II enzymes
including UGTs, COMT, UDP-glucose-dehydrogenase (UDP-Glu-DH), breast cancer resistance protein
(BCRP), and β-glucosidase in 15 tissues were determined. Fourteen out of 15 tissues contained
sodium-dependent SGLT1. Another important finding was the detection of protocatechuic acid
glucuronide in post-rinse saliva. Inter-donor differences in salivary anthocyanin levels were also
apparent. The greatest inter-donor variability was noted at the early (0, 5, and 30 min) time points,
and most apparent in cyanidin-3-rutinoside (predominant BRB anthocyanin) and protocatechuic acid
(stabilized metabolite). Average inter-donor differences at early time points were 5-fold, with ranges
from 3.6- to 10.3-fold.
Riches et al. [53] studied different SULT enzymes (SULT1A1, SULT1A3/4, SULT1B1, SULT1E1,
and SULT2A1) which were obtained from human adult’s liver, small intestine, kidney, and lung.
They detected the five major SULTs in human liver, small intestine, kidney, and lung cytosol and showed
variation between individuals and tissues. There was great variation between individuals in SULT in
liver, that is, SULT1A1, SULT1B1, SULT1E1, and SULT2A1. Inter-individual variability of SULTA1
attributed to coding region single nucleotide polymorphism and gene copy number polymorphism.
SULT1B1 and SULT1A3 are two of the most dominant SULT in gastrointestinal tract tissues, and
then SULT1A1, SULT1E1, and SULT2A1, respectively. In kidney, SULT1A1, SULT1B1, SULT1A3, and
SULT2A1, at very low levels, have been detected, but not SULT1E1. Conversely, in lung, SULT1E1
showed the higher levels, followed by SULT1A1, SULT1A3, SULT1B1, and SULT2A1. In conclusion, it
was shown that the small intestine has the highest total expression levels of SULT, followed by the
liver, kidney, and lung, respectively. Strong variations were shown between individuals and tissues.
However, no gender-specific or age-specific variations were shown in the SULT liver expression levels.
COMT is ubiquitously present in mammals and catalyzes the O-methylation of a wide variety of
endogenous and exogenous catecholic substrates using S-adenosyl-l-methionine as the methyl donor.
The human COMT exists in a soluble form (S-COMT) and a membrane-bound form (MB-COMT).
Bai et al. [54] showed that when the flavonoid catechin was used as substrate, the formation of
3’-O-methylation products was favored over the 4’-O-methylated products and that MB-COMT
had higher binding affinity for 3-O-methylation than S-COMT. Two COMT genotypes have been
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described, GG and AA. It has been shown that individuals having the GG COMT genotype had
higher urinary methylated epigallocatechin concentrations after consuming tea than those with AA
COMT [55]. Besides these enzymes (SULT, UGT, COMT, etc.), Fernandes et al. [45] indicated that brush
border membrane enzymes like lactase phloridzin hydrolase (LPH) may participate in hydrolyzation
of anthocyanins and may induce an increase in anthocyanin bioavailability. Németh et al. [51]
demonstrated that LPH and cytosolic β-glucosidase can hydrolyze different types of flavonoids
glycosides, which suggests a possible hydrolysis of anthocyanins by LPH and cytosolic β-glucosidase.
Additionally, they observed significant variability in activity of β-glucosidase isolated from different
human small intestine samples. These results may serve as a base to better understand the possible
effect of enzymatic variations on the inter-individual variations encountered in anthocyanin’s ADME.
6. Effect of the Microbiota on Inter-Individual Variability of Anthocyanin Bioavailability
Among the factors that might affect the inter-individual variation of anthocyanins bioavailability,
the microbiota composition has emerged as one of the most important and less well known. In the last
fifteen years or so, the number of research papers regarding the microbiota effect on different pathological
or physiological conditions has increased in an exponential way. Microbiota catabolism leads to
production of new anthocyanin metabolites in the human gut. These metabolites may be absorbed by
the colon epithelium and induce modulation of the microbiota composition. The bioavailability of
anthocyanins depends on gut microflora and their biotransformation mechanisms. Gut microbiota
vary on a person-to-person basis and in this sense, an inter-individual variability in anthocyanin
ADME could be expected. In general, it is now assumed that if anthocyanins have a beneficial effect on
human health, this effect is mediated by what is called breakdown metabolites, formed by the different
bacteria existing in the microbiota. However, when searching in electronic databases (Medline PubMed
and Web of Science) for anthocyanins and microbiota, less than 200 articles were initially selected.
After removal of duplicates and an initial screening, 43 articles were selected for further reading.
After detailed analysis of the full text, 12 articles were rejected, due to lack of relevant outcomes, aspects
of the study design, and so forth. Finally, articles published between 2005 and 2018 were incorporated
in this review (see Tables 3–5). Other articles were not selected because, for example, the polyphenol
composition of the dietary sources of anthocyanins was too complex or because anthocyanins did
not represent a big proportion with respect to the total polyphenol content (i.e., grape juice or red
wine extract), although they suggested a role of the human intestinal microbiota on anthocyanins
metabolism [56,57].
After raspberry consumption, a large number of polyphenol metabolites were quantified in human
urine by Ludwig et al. [58], including the ones already described and others including methyl-, glycine-,
glucuronide-, and sulfate derivatives of phenolic acids and phenylpropanoids. Very interestingly,
Ludwig et al. [58] showed that due to the early appearance of 4′-hydroxyhippuric acid and ferulic
acid derivatives in plasma, these metabolites may be absorbed, maybe after degradation in the upper
gastrointestinal tract, without any microflora intervention on their metabolism.
Another reason for not including some papers in the table is the use of food extracts or food products
in which anthocyanins do not represent the main source of polyphenols and from which the formation
of metabolites cannot be confirmed. One example is the study of Burgos-Edwards et al. [59], in which a
number of metabolites, including 3-coumaroylquinic acid, feruloylquinic acid, quercetin-3-rutinoside,
or vitexin, were found after fermentation with human feces of a red Chilean currant. However, these
compounds are very unlikely anthocyanin metabolites, and it is difficult to conclude about which
polyphenol they are derived from.
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Table 3. Microbial metabolites of anthocyanins and bacteria regulated by anthocyanins.
Species Anthocyanins Model Metabolites Found Bacterial Species Ef Reference





Bac C3G, C3R(mulberry) in vitro




Streptococcus thermophiles ↑ [61]
Bac C3G(black rice) in vitro


























Bac Mv deriv(red grape) in vitro E. coli ↓ [64]
Human




























































catechol, resorcinol, pyrogallol [71]












Human C3Ga, C3A(Arbutus unedo)
anaerobic
culture 3,4-(Dihydroxyphenyl)-acetic acid [72]






Human M3G (red wine) In vivo




C3G: cyanidin-3-glucoside; C3R: cyanidin-3-rutinoside; C3GR: cyanidin-3-glucosyl-rutinoside; Pn: Peonidin;
Mv: malvidin; D3R: delphinidin-3-rutinoside; M3G: malvidin-3-glucoside; P3G: pelargodin-3-glucoside; P3R;
pelargonidin-3-rutinoside; Cy: cyanidin; Pt3G: petunidin-3-glucoside; C3Ga: cyanidin-3-galactoside; C3A:
cyandin-3-arabinoside; Pn3G; peonidin-3-glucoside; MGa: malvidin galactoside; Bac: bacteria; deriv: derivatives;
Ef: sense of the regulation, effect; ↑: increase in bacterial growth; ↓: decrease in bacterial groth; NC: no change.
Early in vitro studies revealed that bacterial metabolism of anthocyanins leads to the cleavage
of glycosidic linkages and breakdown of the anthocyanidin heterocycle. As a result of this
breakdown, anthocyanins generate new metabolites via gut microbiota. The type and amount
of these metabolites hinge on the structure of food matrix, anthocyanin source, gut composition,
and bacterial interaction with anthocyanins [68,69]. After colonic fermentation, different gut
metabolites are formed from different anthocyanins. For example, after the gut metabolism of cyanidin
derivatives, the metabolites generally formed are protocatechuic acid, vanillic acid and p-coumaric
acid, 2,4,6-trihydroxybenzaldehyde, gallic acid, syringic acid and 2,4,6-trihydroxybenzaldehyde,
2,3-dihydroxybenzoic acid, 3-hydroxycinnamic acid, and 3-hydroxyphenylpropionic acid [41,60,75,76].
On the other hand, malvidin derivatives bring in syringic acid, p-coumaric acid, 4-hydroxybenzoic, and
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homovanillic acid [67,74], and pelargonidin-3-glucoside produces tyrosol, hydroxyphenylpropionic
acid, hydroxyphenylacetic acid, and p-hydroxybenzoic acid [66].
Table 4. Microbial metabolites of anthocyanins.
Species Anthocyanins Model Metabolites Found Reference
Pig D3G, PT3G, P3G,M3G (red grape) anaerobic culture
3-O-methylgallic acid, syringic acid,
2,4,6-trihydroxybenzaldehyde [77]
Rat C3G, C3R, D3R(mulberry) anaerobic culture




Rat Cy deriv (Blackraspberry) In vivo
3-OHphenylpropionic, 3-hydroxybenzoic,
3-OHcinnamic acids [75]
Rat C3G In vivo protocatechuic acid [41]
C3G: cyanidin-3-glucoside; D3R: delphinidin-3-rutinoside; M3G: malvidin-3-glucoside; C3R: cyanidin-3-rutinoside
Pn: P3G: peonidin-3-glucoside; Cy deriv: cyanidin derivatives.
Other recent studies have shown that red wine and red wine products, which are rich sources
of anthocyanin, produce syringic acid, dihydroxylated benzene, catechol/pyrocatechol, vanillic
acid, protocatechuic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde after colonic
fermentation [67,69,77]. However, Sánchez-Patán et al. [56] did not observe a significant increase in
protocatechuic, gallic and vanillic acid levels during fecal fermentation of a similar polyphenol source.
Berries are one of the most studied fruits regarding anthocyanin metabolism. Several studies with
human feces and rat feces have shown that protocatechuic, 3-hydroxyphenylpropionic, pyrogallol,
3,4-dihydroxybenzoic acid, and tyrosol are the main metabolites formed after colonic fermentation
of berries. These studies prove that mono and di-glycosidic anthocyanins are rapidly catabolized by
colonic microbiota [71,76]. In some cases, the production of specific metabolites, that is, O-methylated
metabolites from malvidin and petunidin increase their bioactivity [78] (Table 5). On the other
hand, glycosylation and acetylation of anthocyanins, while conferring increased stability in the
gastrointestinal tract, showed a decreased bioactivity. Some authors have reported hippuric acid as
the main anthocyanin metabolite derived from microbial metabolism, however, it is well known that
hippuric acid is a rather unspecific metabolite that can be formed after ingestion of other families of
polyphenols (i.e., proanthocyanins) [75].
Besides, Cheng et al. [61] studied five intestinal bacteria after incubation with mulberry
anthocyanins under anaerobic conditions and identified chlorogenic acid, cryptochlorogenic acid,
caffeic acid, and ferulic acid. They concluded that protocatechuic acid, chlorogenic acid, and ferulic
acid are microbial metabolites formed by bacterial β-glucosidase action. However, they proposed that
the production of chlorogenic acid and cryptochlorogenic acid were derived from chemical degradation
of anthocyanins and not from bacterial action. However, it should be noted that chlorogenic and
cryptochlorogenic acids might well derive from other compounds present in the extract and not only
from anthocyanins.
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Table 5. Gut bacteria regulated by anthocyanins.
Species Anthocyanins Model Bacterial species Ef Reference









Mv deriv, Pt deriv, D deriv
(blueberry)
D deriv, Cy deriv
(blackcurrant)
Mv deriv, Pt deriv, D deriv
(red grape)
Cy deriv (black raspberry)













Rat Pn3Ga (cranberry) In vivo Verrucomicrobia Akkermansia ↑ [80]















Rat C3R, C3G, C3G (dark sweetcherry) In vivo
Akkermansia, Bacteroidaceae,
Lactobacillus ↑ [82]












C3G: cyanidin-3-glucoside; D3R: delphinidin-3-rutinoside; Pt3R: petunidin-3-rutinoside; M3G: malvidin-3-glucoside;
M3Ga: malvidin-3-glacatoside; Pn: peonidin; P3Ga: peonidin-3-galactoside; Mv: malvidin; Pt: petunidin; D:
delphinidin; Cy: cyanidin; deriv: derivatives; Ef: sense of the regulation, effect; ↑: increase in bacterial growth; ↓:
decrease in bacterial groth; NC: no change.
In general, most authors analyze anthocyanin metabolites in in vitro fermentation or in vivo
ingestion assays after 8 h or longer. Faria et al. [84] showed that the highest recovery of anthocyanin
metabolites in feces was seen after 24 h of consumption. Czank et al. [43] reported that a remarkable
part of cyanidin-3-glucoside metabolites did not reach maximal concentrations in fecal samples until
48 h of interaction. They proposed, in this sense, that a longer fecal sampling period (perhaps ≥72 h)
might show better recoveries. However, some of the fermentation studies showing the presence of the
aglycon cyanidin or the formation of the glucoside of cyanidin after fermentation of the rutinoside
used shorter times (e.g., 2 h in Aura et al. [69]).
Several authors have shown that bacterial enzymatic activity affects the catabolism of anthocyanins.
Generally, intestinal microbiota has β-D-glucosidase, β-D-glucuronidase, α-galactosidase, and
α-rhamnosidase activity. Gut microbiota breaking of glycosidic linkages and breakdown of
anthocyanidin heterocycle are both meditated via bacterial enzymatic activity. This way, anthocyanins
are transformed into their more bioavailable forms that, in turn, may regulate the colonic microbiota
composition (Figure 2) [61,76,81,84].
Many studies reveal that after the consumption of anthocyanins, beneficial bacteria such
as Bifidobacterium spp., Lactobacillus spp., or Actinobacteria populations are increased in the gut
microbiota [61–63,73,79,82]. These bacteria contribute in different ways to human health as they
participate in the metabolism of phenolic compounds, enhance gut barrier function, increase mucus
secretion, produce short-chain fatty acids, or regulate lipid metabolism (see Figure 2) [82,84].
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A recent in vitro work with bacterial strains demonstrated that after the incubation of black
rice anthocyanins, Bifidobacteria and Lactobacillus increased and pH values decreased [62]. Similarly,
Sun et al. [63] reported that after the incubation of peonidin derivatives with different bacterial strains,
the pH values decreased and the bacterial growing rate of Bifidobacterium bifidum, Bifidobacterium
adolescentis, Bifidobacterium infantis, and Lactobacillus acidophilus increased. They concluded that the
metabolism of anthocyanins by microbiota bacteria produces the breakdown of β-glucoside bonds and
the production of short-chain fatty acids (SCFA) alongside phenolic acids, which triggers the decrease
of pH and ensures a suitable media for proliferation of probiotic bacteria.
In another study, after the colonic metabolism of jucara pulp, Guergoletto et al. [70] observed
that although Lactobacillus/Enterococcus spp. did not modify their growing rate, Bifidobacterium spp.,
Eubacterium rectale–Clostridium coccoides group, and Bacteroides spp.–Prevotella group did. In parallel,
there was an increase in SCFA levels. In a similar way, dietary cherry supplementation promotes
SCFA production in gut microbiota and provides an increase in beneficial bacteria (i.e., Bacteroidaceae,
Akkermansia), in this case showing that the increase in SCFA is associated with Akkermansia [82].
Similarly, Anhê et al. [80] showed that after consumption of a cranberry extract, there was an increase
in Akkermansia that was associated with an enhancement of the gut barrier function via mucus secretion
stimulation. In the light of all the above, we can conclude that anthocyanins are metabolized by specific
bacteria in the gut microbiota and that, in turn, they are able to modify selectively the growing rate
of specific bacterial groups [63,65,85]. Moreover, gut microbiota is extremely complex and shows
large variability, both intra-individually and inter-individually, depending on the age, body weight,
genetics, disease state, and dietary habits. Therefore, we could assume that much of the variability on
anthocyanins ADME could be due to changes in microbiota composition [82,85].
Although many studies reported that after anthocyanin colonic fermentation many beneficial
bacteria like Bifidobacterium spp., Actinobacteria, Bacteroidetes, Lactobacillus/Enterococcus spp.,
Akkermansia [62,67,74,80,82,83] increase, Sánchez-Patán et al. [56] failed to show any change for
Bifidobacterium spp., Lactobacillus/Enterococcus spp., Bacteroides. On the other hand, Overall et al. [78]
showed that different profiles of anthocyanins from different sources can have a different impact on
the gut microbiota. After colonic fermentation of black berry and black raspberry, Actinobacterıa levels
remained unchanged, while they proliferated with concord grape, blackcurrant, or blueberry [78].
Besides, they showed that after the consumption of the berries there was a reduction in oxygen tension
in the gut lumen that lead to the growth of oxygen-sensitive bacteria.
Anthocyanins can not only enhance beneficial bacteria in gut microbiota, but also reduce
some harmful bacteria. Guergoletto et al. [70] and Flores et al. [68] showed that C. histolyticum is
significantly decreased after colonic fermentation of certain anthocyanins (cyanidin and delphinidin
derivatives mainly). However, this effect did not show up when the source of anthocyanin
was malvidin-3-glucoside [68]. In addition, Hidalgo et al. [67] indicated that after the colonic
fermentation of malvidin-3-glucoside, C. histolyticum decreased, although not significantly. Similarly,
Sánchez-Patán et al. [56] observed a slight but not significant inhibition of C. histolyticum, but did not
detect any changes in beneficial bacteria. Trikas et al. [64] reported that anthocyanins of wine and
wine by-product extracts inhibited E. coli and S. aureus. Similarly, Lacombe et al. [83] showed that
Enterococcus is decreased in feces of rat that were feed with low-bush berry for 6 weeks. These recent
studies proved that anthocyanins have the capacity to modulate gut microbiota, bringing out beneficial
changes (see Figure 2).
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Figure 2. Scheme of Anthocyanins ADME (absorption, metabolism, distribution, and excretion) and
structure of the main metabolites.
It is difficult to concretely conclude on anthocyanin metabolism and biotransformation by the gut
microbiota. Although the scientific literature differs in many ways, such as the source of anthocyanins,
food matrix, or in vivo or in vitro model, it can be concluded that anthocyanins and their metabolites
generally have a positive impact on microbiota. However, this effect may show variability depending
on genetic, physiological, and pathological state. Therefore, the metabolism of anthocyanins by gut
microflora and the associated inter-individual variability is an aspect that needs to be better studied in
the future.
7. Conclusions
There is an evident inter- and intra-individual variability in anthocyanins ADME that will
undoubtedly have an effect on anthocyanins efficacy. There are, however, only few studies published
so far that describe this variability and even less that aimed to study the role of different of different
factors on this inter or intra-individual variability. Nonetheless, looking at the existing bibliography
we could assume that there are three main factors that will likely affect anthocyanins ADME, which
are food matrix and food processing, enzymatic levels that, in turn, are affected by genetic factors, but
also by the diet, age, sex, and so forth, and the microbiota functionality, which again can be modified
depending on age, diet, physiological, genetic, and pathological factors.
It is clear from the literature currently available that, even if some of the described metabolites
generated through gut bacteria metabolism are quite robust and can probably be used as biomarkers
of anthocyanin consumption, more studies are needed in order to establish which species are involved
in anthocyanin metabolism in order to clarify the effect of microbiota variability on the inter-individual
variation encountered in humans in terms of anthocyanin bioavailability. One can assume that
the breakdown products generated from anthocyanins are due either to nonenzymatic degradation
or to microbiota activity, but at the moment there are not enough studies in which we can base
solid conclusions.
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